论文部分内容阅读
目的探讨“双核”(丙肝治病和防病相结合)驱动管理模式在丙肝筛查与管理体系中的应用效果。方法依托信息手段,对丙肝患者进行电子建档、跟踪随防、规范治疗、全程督导与健康教育等,为丙肝患者提供全程、专业、优质服务。结果体系实施后HCV RNA检测率由59.30%上升至68.90%,医务人员对HCV感染高危人群丙肝筛查率为96.90%,丙肝患者对症治疗率为59.40%,丙肝联合用药率为92.70%,患者对丙肝知晓率为75.60%,对丙肝健康宣教的满意度为85.20%,差异明显具有统计学意义(P<0.05)。结论把丙肝监督管理与规范治疗有机结合起来,治防并举,“双核”驱动,统筹兼顾,科学评价,持续改进,可有效预防与控制传染病发生,促进丙肝防控工作可持续发展。
Objective To explore the application effect of “dual-core” (hepatitis C combined with disease prevention) driving management mode in hepatitis C screening and management system. Methods Based on information, hepatitis C patients were electronically filmed, followed up with anti-normative treatment, full supervision and health education, and provided full, professional and quality services for patients with hepatitis C. Results After the system was implemented, the detection rate of HCV RNA increased from 59.30% to 68.90%. The medical staff’s screening rate of HCV was 96.90% in HCV-infected high-risk population, 59.40% in HCV-infected patients and 92.70% in HCV-infected patients. Hepatitis C awareness was 75.60%, satisfaction with Hepatitis C health education was 85.20%, the difference was statistically significant (P <0.05). Conclusion Combining the supervision and management of hepatitis C with standardized treatment, prevention and control are both driven by both prevention and prevention, taking all factors into consideration, scientific evaluation and continuous improvement, which can effectively prevent and control the occurrence of infectious diseases and promote the sustainable development of prevention and control of hepatitis C.